|
SSX2IP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.185400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.949600E-01 |
| Normal-vs-Stage2 |
1.028590E-01 |
| Normal-vs-Stage3 |
2.292600E-01 |
| Normal-vs-Stage4 |
3.273200E-01 |
| Stage1-vs-Stage2 |
6.017600E-01 |
| Stage1-vs-Stage3 |
1.867430E-01 |
| Stage1-vs-Stage4 |
2.519200E-01 |
| Stage2-vs-Stage3 |
5.268000E-02 |
| Stage2-vs-Stage4 |
1.335770E-01 |
| Stage3-vs-Stage4 |
8.772000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.752400E-01 |
| Normal-vs-AfricanAmerican |
5.873800E-02 |
| Normal-vs-Asian |
7.072000E-01 |
| Caucasian-vs-AfricanAmerican |
1.370410E-01 |
| Caucasian-vs-Asian |
7.454800E-01 |
| AfricanAmerican-vs-Asian |
5.415200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.293400E-01 |
| Normal-vs-Female |
2.956200E-01 |
| Male-vs-Female |
2.263000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.362400E-01 |
| Normal-vs-Extreme_Weight |
2.016800E-01 |
| Normal-vs-Obese |
4.812200E-01 |
| Normal-vs-Extreme_Obese |
1.008240E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.734800E-01 |
| Normal_Weight-vs-Obese |
6.364800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.494200E-01 |
| Extreme_Weight-vs-Obese |
2.704600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.403400E-01 |
| Obese-vs-Extreme_Obese |
2.379800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.415000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.234600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.354200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.097000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.763400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.032000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.984400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.277000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.963800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.740600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.955800E-03 |
| Normal-VS-Type2 PRCC |
1.432250E-01 |
| Normal-VS-KIRP CIMP |
9.791800E-02 |
| Normal-VS-Unclassified PRCC |
8.720000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.582200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.469600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.146390E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.720200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.405790E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.518200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.178000E-01 |
| Normal-vs-N1 |
6.819800E-02 |
| Normal-vs-N2 |
4.293600E-01 |
| N0-vs-N1 |
4.663900E-02 |
| N0-vs-N2 |
4.137000E-01 |
| N1-vs-N2 |
5.398200E-01 |
|
|
